Hydreight Announces Normal Course Issuer Bid
30 September 2024 - 9:00PM
Hydreight Technologies Inc. (TSXV: NURS) (OTCQB: HYDTF)
(FSE:SO6) (the “
Company”), a fast-growing
mobile clinical network and medical platform which enables flexible
at-home medical services across 50 states in the United States,
announces today its intention to make a normal course issuer bid
(the "
Bid") to purchase for cancellation, from
time to time, as it considers advisable, up to 1,378,633 of its
issued and outstanding common shares, being approximately 3.42% of
the Company's currently outstanding common shares and approximately
10.0% of 13,786,334 which represents the Company's Public Float (as
that term is defined in the policies of the TSX Venture Exchange
(the "
Exchange"). The Bid will commence on October
4, 2024, and will terminate on October 3, 2025, or such earlier
time as the Bid is completed or at the option of the Company.
Research Capital Corporation of Vancouver, British Columbia will
conduct the Bid on behalf of the Company.
The Bid will be conducted in accordance with
applicable securities laws and the policies of the Exchange.
Purchases will be made on the open market through the facilities of
the Exchange. The price which the Company will pay for any shares
purchased by it will be the prevailing market price of such common
shares on the Exchange at the time of such purchase. The purchase
of the common shares under the Bid is being funded from existing
working capital.
In accordance with Exchange policies, the
Company will include a summary of the Bid in the management
information circular to be mailed to shareholders of the Company in
respect of its next meeting of shareholders.
The Company believes that purchases of its
common shares pursuant to the Bid may contribute to the
facilitation of an orderly market and is in the best interests of
the Company and its shareholders. In the event that the Company
believes that its common shares begin trading in a price range that
does not adequately reflect their underlying value based on the
Company’s business prospects, growth and financial position, the
Company may purchase common shares pursuant to the Bid.
On behalf of the Board of Directors Shane Madden
Director and Chief Executive Officer Hydreight Technologies Inc.
Contact
Email: ir@hydreight.com; Telephone: (480) 790
6886
Neither the TSX Venture Exchange nor its
Regulation Services Provider (as the term is defined in the
Policies of the TSX Venture Exchange) accepts responsibility for
the adequacy or accuracy of this release.
Caution Regarding Forward-Looking Statements -
This news release contains certain forward-looking statements,
including statements regarding the Bid. These statements are
subject to a number of risks and uncertainties. Actual results may
differ materially from results contemplated by the forward-looking
statements. When relying on forward-looking statements to make
decisions, investors and others should carefully consider the
foregoing factors and other uncertainties and should not place
undue reliance on such forward-looking statements. The Company does
not undertake to update any forward looking statements, oral or
written, made by itself or on its behalf, except as required by
applicable law.
Hydreight Technologies (TSXV:NURS)
Historical Stock Chart
From Oct 2024 to Nov 2024
Hydreight Technologies (TSXV:NURS)
Historical Stock Chart
From Nov 2023 to Nov 2024